Featured Research

from universities, journals, and other organizations

Potential therapeutic target for controlling obesity discovered

Date:
June 15, 2011
Source:
The Mount Sinai Hospital / Mount Sinai School of Medicine
Summary:
A new study has found that a cellular signaling pathway governs the differentiation of cells into fat tissue or smooth muscle, which lines the vascular system. Engaging this signaling pathway and its capacity to govern cell differentiation has important implications in preventing obesity and cardiovascular disease.

A new study from Mount Sinai School of Medicine has found that a cellular signaling pathway governs the differentiation of cells into fat tissue or smooth muscle, which lines the vascular system. Engaging this signaling pathway and its capacity to govern cell differentiation has important implications in preventing obesity and cardiovascular disease. The study is published in the June issue of Developmental Cell.

Related Articles


This research, by Philippe M. Soriano, PhD, Professor, Developmental and Regenerative Biology at Mount Sinai School of Medicine, and Lorin E. Olson, PhD, previously a postdoctoral fellow in the laboratory who is now an Assistant Member of the Immunobiology & Cancer Research Program at the Oklahoma Medical Research Foundation, is a novel in vivo study to evaluate the signaling activity of the Platelet Derived Growth Factor Receptor-beta (PDGFRβ). The research team used mice that were genetically engineered to have elevated PDGFRβ signaling. They found that elevated PDGFRβ signaling inhibits differentiation of immature mesenchymal stem cells. These cells have the ability to give rise to multiple cell types in the organism, including fat cells and vascular smooth muscle.

"How mesenchymal cells are regulated within the body had been unclear until now. Our research is the first done in animals to show that PDGFRβ is a key regulator of cellular differentiation into fat cells or smooth muscle cells," said Dr. Soriano. "These data indicate that PDGFRβ plays a critical role in determining their cellular fate, providing a new therapeutic target in preventing the onset of diseases like obesity."

The researchers caution, based on their previous research published in Developmental Cell, that some types of chronic activation of PDGFR receptors may result in tumor formation. Therefore, signaling events further in the differentiation process may be better therapeutic targets. More research is needed to better understand how PDGFRβ regulates mesenchymal cell differentiation and the immune system's response to that activity to help identify treatments for cardiovascular and obesity-related diseases.

The research was funded by the National Institutes of Health.


Story Source:

The above story is based on materials provided by The Mount Sinai Hospital / Mount Sinai School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lorin E. Olson, Philippe Soriano. PDGFRβ Signaling Regulates Mural Cell Plasticity and Inhibits Fat Development. Developmental Cell, Volume 20, Issue 6, 815-826, 14 June 2011 DOI: 10.1016/j.devcel.2011.04.019

Cite This Page:

The Mount Sinai Hospital / Mount Sinai School of Medicine. "Potential therapeutic target for controlling obesity discovered." ScienceDaily. ScienceDaily, 15 June 2011. <www.sciencedaily.com/releases/2011/06/110614131956.htm>.
The Mount Sinai Hospital / Mount Sinai School of Medicine. (2011, June 15). Potential therapeutic target for controlling obesity discovered. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2011/06/110614131956.htm
The Mount Sinai Hospital / Mount Sinai School of Medicine. "Potential therapeutic target for controlling obesity discovered." ScienceDaily. www.sciencedaily.com/releases/2011/06/110614131956.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com
British Navy Ship Arrives in Sierra Leone With Ebola Aid

British Navy Ship Arrives in Sierra Leone With Ebola Aid

AFP (Oct. 30, 2014) The British ship RFA ARGUS arrived in Sierra Leone to deliver supplies and equipment to help the fight against Ebola. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins